Pharmacology Newswire

Pharmacology Newswire

Comprehensive Real-Time News Feed for Pharmacology.

Results 1 - 13 of 13 in Pharmacology

  1. Therapeutic Drug Monitoring Market with Current Trends Analysis 2015-2025Read the original story w/Photo

    Aug 1, 2017 | PR-inside.com

    Therapeutic drug monitoring is a branch of clinical chemistry and clinical pharmacology which aims at maintaining the drug concentration levels in the body fluids within the particular therapeutic range. The purpose of therapeutic drug monitoring is refining patient care by individually adjusting the drug dosage for better outcomes.

    Comment?

  2. Cellular pharmacology of gemcitabine.Read the original story

    Jun 16, 2017 | CiteULike

    ... structural and pharmacological similarities to Ara-C, gemcitabine displays distinctive features of cellular pharmacology, metabolism and mechanism of action. Following influx through the cell membrane via nucleoside transporters, gemcitabine ...

    Comment?

  3. Attendee List Released for ADMET 2017 featuring AstraZeneca, Bayer,...Read the original story w/Photo

    Jun 5, 2017 | World News Report

    ... and ADMET studies a Explore the latest advancements in drug screening technology a Preclinical PK/PD pharmacology testing and transitional PK/PD a New approaches to estimate the distribution and clearance of large molecules a Listen to reviews of ...

    Comment?

  4. Morris named chair in UB pharmacy schoolRead the original story

    Mar 22, 2017 | UB Reporter

    ... is also past president. Morris is a member of the Food and Drug Administration's Advisory Panel for Clinical Pharmacology and Pharmaceutical Sciences, and was elected a member of the executive committee of the Board of Pharmaceutical Sciences for ...

    Comment?

  5. Marilyn Morris appointed department chair in UB pharmacy schoolRead the original story

    Mar 15, 2017 | University at Buffalo

    ... is also past president. Morris is a member of the Food and Drug Administration's Advisory Panel for Clinical Pharmacology and Pharmaceutical Sciences, and was elected a member of the executive committee of the Board of Pharmaceutical Sciences for ...

    Comment?

  6. Relypsa Announces Publication of Results of Veltassa Drug-Drug...Read the original story w/Photo

    Feb 13, 2017 | GlobeNewswire

    Relypsa, Inc., a Vifor Pharma company, today announced that results of drug-drug interaction studies of VeltassaA for oral suspension were published online by the Journal of Cardiovascular Pharmacology and Therapeutics. Results from 12 individual Phase 1 studies in healthy volunteers of 12 oral medications showed there were no clinically meaningful or statistically significant interactions between Veltassa and the 12 oral medications when taken at least three hours apart.

    Comment?

  7. Therapeutic Drug Monitoring Market Forecast 2015-2025Read the original story w/Photo

    Jan 4, 2017 | PR-inside.com

    Therapeutic drug monitoring is a branch of clinical chemistry and clinical pharmacology which aims at maintaining the drug concentration levels in the body fluids within the particular therapeutic range. The purpose of therapeutic drug monitoring is refining patient care by individually adjusting the drug dosage for better outcomes.

    Comment?

  8. Montefiore Health System and Albert Einstein College of Medicine...Read the original story

    Dec 13, 2016 | Newswise

    ... Psychology from Yale University, his M.D. from Yale University School of Medicine, and his Ph.D. in behavioral pharmacology from the University of Cambridge, United Kingdom, where he was also a Marshall Scholar. He completed residencies at ...

    Comment?

  9. Recommendations for Management of Clinically Significant Drug-Drug...Read the original story

    Nov 22, 2016 | Circulation

    On behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; Council on Quality of Care and Outcomes Research; and Council on Functional Genomics and Translational Biology A drug-drug interaction is a pharmacokinetic or pharmacological influence of 1 medication on another that differs from the known or anticipated effects of each agent alone. 1 A DDI may result in a change in either drug efficacy or drug toxicity for 1 or both of the interacting medications.

    Comment?

  10. Therapeutic Drug Monitoring Market Volume Forecast and Value Chain Analysis 2015-2025Read the original story w/Photo

    Dec 5, 2016 | PR-inside.com

    Therapeutic drug monitoring is a branch of clinical chemistry and clinical pharmacology which aims at maintaining the drug concentration levels in the body fluids within the particular therapeutic range. The purpose of therapeutic drug monitoring is refining patient care by individually adjusting the drug dosage for better outcomes.

    Comment?

  11. Recommendations for Management of Clinically Significant Drug-Drug...Read the original story

    Nov 21, 2016 | Circulation

    On behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; Council on Quality of Care and Outcomes Research; and Council on Functional Genomics and Translational Biology A drug-drug interaction is a pharmacokinetic or pharmacological influence of 1 medication on another that differs from the known or anticipated effects of each agent alone. A DDI may result in a change in either drug efficacy or drug toxicity for 1 or both of the interacting medications.

    Comment?

  12. FDA Approves Supplemental New Drug Application for Veltassa Removing...Read the original story w/Photo

    Nov 26, 2016 | Drugs.com

    ... of the label. In addition, data from the Veltassa drug-drug interaction program has been added to the Clinical Pharmacology section of the label (Section 12). "We are extremely pleased the FDA has approved these changes to Veltassa's label, ...

    Comment?

  13. An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and...Read the original story

    Nov 29, 2016 | The Pharmacogenomics Journal

    Correspondence: Dr AG Vandell, Translational Medicine & Clinical Pharmacology, Daiichi Sankyo Pharma Development, 399 Thornall St, Edison, NJ 08837, USA. E-mail: [email protected] Edoxaban and its low-abundance, active metabolite M4 are substrates of P-glycoprotein and organic anion transporter protein 1B1 , respectively, and pharmacological inhibitors of P-gp and OATP1B1 can affect edoxaban and M4 pharmacokinetics .

    Comment?